Next Article in Journal
Exposure to Passive Smoking among Current Smokers and Non-Smokers
Previous Article in Journal
Komentarz do artykułu W. Owczarka i wsp. "Gruźlica węzłów chłonnych szyi z ogniskiem gruźlicy rozpływnej—Opis przypadku"
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence of Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Population of Adult Asthmatics in Poland Based on an Epidemiological Questionnaire

by
Łukasz Kasper
*,
Krzysztof Sładek
,
Grażyna Bochenek
,
Mariusz Duplaga
and
Andrzej Szczeklik
Department of Medicine, Jagiellonian University Medical College, Skawinska 8, 31-066 Krakow, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2009, 77(5), 431-439; https://doi.org/10.5603/ARM.27776
Submission received: 18 November 2008 / Revised: 12 August 2009 / Accepted: 12 August 2009 / Published: 12 August 2009

Abstract

Introduction: Hypersensitivity reactions to drugs account for 25% of all side effects related to drugs, affecting more than 7% of the population. One in four such reactions is caused by acetylic acid and other non-steroidal anti-inflammatory drugs. Material and Methods: Between 1998 and 2000 epidemiological research was carried out in various centers, with the aim of estimating the frequency of allergy-based diseases in Poland. The objective of the study was to evaluate the frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), based on an epidemiological questionnaire, in the Polish adult population. Results: Bronchial asthma was diagnosed in 582 patients (5.4%). Of that group, 75 patients (12.9%) additionally reported symptoms of hypersensitivity to NSAIDs. Aspirin-induced asthma was diagnosed in 11 patients (14.7%) with clinical manifestations of hypersensitivity responses. Frequency of aspirin-induced asthma with clinical symptoms amounted to 1.9% of asthmatics. In the assessment of severity of the disease, aspirin intolerance was the only statistically significant factor (p = 0.0003; odds ratio 28.6 with assumed 95% confidence interval). Conclusions: In the population of adults in Poland, the frequency of aspirin-induced asthma amounted to 0.1%. Hypersensitivity to NSAIDs was observed in 12.9% of asthmatics. In asthmatics with symptoms of hypersensitivity to non-steroidal anti-inflammatory drugs, which takes the course of clinically demonstrable aspirin-induced asthma, the risk of severe asthma is 30-fold higher.
Keywords: asthma; prevalence; aspirin induced asthma; non-steroidal anti-inflammatory drugs; hypersensitivity asthma; prevalence; aspirin induced asthma; non-steroidal anti-inflammatory drugs; hypersensitivity

Share and Cite

MDPI and ACS Style

Kasper, Ł.; Sładek, K.; Bochenek, G.; Duplaga, M.; Szczeklik, A. Prevalence of Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Population of Adult Asthmatics in Poland Based on an Epidemiological Questionnaire. Adv. Respir. Med. 2009, 77, 431-439. https://doi.org/10.5603/ARM.27776

AMA Style

Kasper Ł, Sładek K, Bochenek G, Duplaga M, Szczeklik A. Prevalence of Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Population of Adult Asthmatics in Poland Based on an Epidemiological Questionnaire. Advances in Respiratory Medicine. 2009; 77(5):431-439. https://doi.org/10.5603/ARM.27776

Chicago/Turabian Style

Kasper, Łukasz, Krzysztof Sładek, Grażyna Bochenek, Mariusz Duplaga, and Andrzej Szczeklik. 2009. "Prevalence of Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Population of Adult Asthmatics in Poland Based on an Epidemiological Questionnaire" Advances in Respiratory Medicine 77, no. 5: 431-439. https://doi.org/10.5603/ARM.27776

Article Metrics

Back to TopTop